SGRY vs. THC
SGRY (Surgery Partners, Inc.) and THC (Tenet Healthcare Corporation) are both stocks. Both operate in the Medical Care Facilities industry within the Healthcare sector. Over the past 10 years, SGRY returned -0.48%/yr vs 19.01%/yr for THC. A 0.54 correlation means they provide meaningful diversification when combined.
Performance
SGRY vs. THC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SGRY achieves a -12.56% return, which is significantly higher than THC's -17.05% return. Over the past 10 years, SGRY has underperformed THC with an annualized return of -0.48%, while THC has yielded a comparatively higher 19.01% annualized return.
SGRY
- 1D
- -1.89%
- 1M
- -4.86%
- YTD
- -12.56%
- 6M
- -20.72%
- 1Y
- -41.97%
- 3Y*
- -30.23%
- 5Y*
- -25.92%
- 10Y*
- -0.48%
THC
- 1D
- 0.76%
- 1M
- -11.07%
- YTD
- -17.05%
- 6M
- -22.00%
- 1Y
- -4.07%
- 3Y*
- 30.26%
- 5Y*
- 19.47%
- 10Y*
- 19.01%
SGRY vs. THC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SGRY Surgery Partners, Inc. | -12.56% | -27.02% | -33.82% | 14.82% | -47.84% | 84.11% | 85.31% | 59.91% | -19.09% | -23.66% |
THC Tenet Healthcare Corporation | -17.05% | 57.43% | 67.04% | 54.89% | -40.27% | 104.58% | 5.00% | 121.88% | 13.06% | 2.16% |
Correlation
The correlation between SGRY and THC is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.33 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.50 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.61 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.56 |
Correlation (All Time) Calculated using the full available price history since Oct 2, 2015 | 0.54 |
Over the past year, the correlation between SGRY and THC has dropped to 0.33 - well below their long-term average of 0.54, suggesting their price drivers have been diverging.
Fundamentals
SGRY:
$1.73B
THC:
$14.44B
SGRY:
-$0.60
THC:
$21.43
SGRY:
0.51
THC:
0.68
SGRY:
1.03
THC:
3.00
SGRY:
$3.34B
THC:
$21.46B
SGRY:
$763.30M
THC:
$12.91B
SGRY:
$787.20M
THC:
$4.00B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SGRY vs. THC — Risk / Return Rank
SGRY
THC
SGRY vs. THC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Surgery Partners, Inc. (SGRY) and Tenet Healthcare Corporation (THC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SGRY | THC | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.91 | -0.10 | -0.80 |
Sortino ratioReturn per unit of downside risk | -1.09 | 0.13 | -1.22 |
Omega ratioGain probability vs. loss probability | 0.83 | 1.02 | -0.18 |
Calmar ratioReturn relative to maximum drawdown | -0.81 | -0.12 | -0.69 |
Martin ratioReturn relative to average drawdown | -1.41 | -0.33 | -1.07 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SGRY | THC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.91 | -0.10 | -0.80 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.48 | 0.44 | -0.92 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.01 | 0.34 | -0.35 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.04 | 0.11 | -0.15 |
Drawdowns
SGRY vs. THC - Drawdown Comparison
The maximum SGRY drawdown since its inception was -82.86%, smaller than the maximum THC drawdown of -98.28%. Use the drawdown chart below to compare losses from any high point for SGRY and THC.
Loading charts...
Drawdown Indicators
| SGRY | THC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.86% | -98.28% | +15.42% |
Max Drawdown (1Y)Largest decline over 1 year | -51.80% | -33.17% | -18.63% |
Max Drawdown (3Y)Largest decline over 3 years | -74.52% | -36.90% | -37.62% |
Max Drawdown (5Y)Largest decline over 5 years | -82.86% | -58.88% | -23.98% |
Max Drawdown (10Y)Largest decline over 10 years | -82.86% | -71.68% | -11.18% |
Current DrawdownCurrent decline from peak | -79.85% | -32.66% | -47.19% |
Average DrawdownAverage peak-to-trough decline | -41.55% | -51.56% | +10.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 29.84% | 12.23% | +17.61% |
Volatility
SGRY vs. THC - Volatility Comparison
The current volatility for Surgery Partners, Inc. (SGRY) is 9.69%, while Tenet Healthcare Corporation (THC) has a volatility of 11.16%. This indicates that SGRY experiences smaller price fluctuations and is considered to be less risky than THC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SGRY | THC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.69% | 11.16% | -1.47% |
Volatility (6M)Calculated over the trailing 6-month period | 28.92% | 27.61% | +1.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.42% | 39.17% | +7.25% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 54.68% | 44.28% | +10.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 64.75% | 56.30% | +8.45% |
Dividends
SGRY vs. THC - Dividend Comparison
Neither SGRY nor THC has paid dividends to shareholders.
Financials
SGRY vs. THC - Financials Comparison
This section allows you to compare key financial metrics between Surgery Partners, Inc. and Tenet Healthcare Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SGRY vs. THC - Profitability Comparison
SGRY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Surgery Partners, Inc. reported a gross profit of 160.20M and revenue of 810.90M. Therefore, the gross margin over that period was 19.8%.
THC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Tenet Healthcare Corporation reported a gross profit of 3.19B and revenue of 5.37B. Therefore, the gross margin over that period was 59.5%.
SGRY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Surgery Partners, Inc. reported an operating income of 65.80M and revenue of 810.90M, resulting in an operating margin of 8.1%.
THC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Tenet Healthcare Corporation reported an operating income of 1.30B and revenue of 5.37B, resulting in an operating margin of 24.1%.
SGRY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Surgery Partners, Inc. reported a net income of -35.90M and revenue of 810.90M, resulting in a net margin of -4.4%.
THC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Tenet Healthcare Corporation reported a net income of 906.00M and revenue of 5.37B, resulting in a net margin of 16.9%.
Frequently Asked Questions
SGRY and THC have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
THC has higher volatility (11.16%) compared to SGRY (9.69%). In terms of maximum drawdown, SGRY dropped -82.86% vs THC's -98.28%.
THC currently has the higher Sharpe Ratio (-0.10 vs -0.91), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SGRY and THC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer